Abstract IA26: Exploiting altered metabolism as a therapeutic strategy for RAS-driven cancers
Sign Up to like & getrecommendations! Published in 2023 at "Molecular Cancer Research"
DOI: 10.1158/1557-3125.ras23-ia26
Abstract: We recently determined that concurrent inhibition of autophagy, using the lysosomal inhibitor chloroquine (CQ), and of ERK, using a small molecule ERK inhibitor (ERKi), synergistically suppressed the growth of pancreatic ductal adenocarcinoma (PDAC) cell lines… read more here.
Keywords: inhibition; exploiting altered; therapeutic strategy; metabolism therapeutic ... See more keywords